01:18 PM EST - West Island Brands Inc : Announces the Company's subsidiary, RoyalMax Biotechnology Canada Inc. D.B.A. West Island Culture, has completed and submitted the required materials to amend the Company's Health Canada license to enable the sale of cannabis extracts, including hashish, as per Cannabis 2.0. Once amended, West Island will be authorized upon receipt to process and sell Cannabis 2.0 products directly to provincial distributors and other authorized Canadian retail supply channels. West Island Brands Inc
shares C.WIB are trading down $0.03 at $0.30.
